Four-year clinical and echocardiographic outcomes after tricuspid valve replacement using a novel bovine pericardial valve bioprosthesis

Abdullatif Abo Dan, Mahée Côté, Anya Chabane, Paul Borchiellini, Philippe Demers, Michel Pellerin, Pierre-Emmanuel Noly, Denis Bouchard · 2026

Read Four-year clinical and echocardiographic outcomes after tricuspid valve replacement using a novel bovine pericardial valve bioprosthesis by Abdullatif Abo Dan, Mahée Côté, Anya Chabane, Paul Borchiellini, Philippe Demers, Michel Pellerin, Pierre-Emmanuel Noly, Denis Bouchard (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13477042.txt.

Description

Abdullatif Abo Dan and co-authors report four years with a new tissue valve in the heart's tricuspid spot in this 2026 paper. The bovine pericardial valve was designed for another position and used here off-label. Records cover eighty-two patients treated from 2021 to 2025. Most were older and badly symptomatic.

No valve clots appeared, and only two patients needed a repeat procedure for severe leakage. Pressure gradients across the valve stayed low and steady. Early risk was real, though: about one in six patients died within thirty days, and a fifth needed a pacemaker. The authors judge the valve's flow performance sound in a very sick group.

Catalog record

CREATORAbdullatif Abo Dan, Mahée Côté, Anya Chabane, Paul Borchiellini, Philippe Demers, Michel Pellerin, Pierre-Emmanuel Noly, Denis Bouchard
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13477042

Browse the full library · About the Tower of Babel